Fangzhou Inc

6086•Hong Kong Stock Exchange

Healthcare Hong Kong Pharmaceutical Retailers

Need professional-grade analysis? Visit stockanalysis.com

HK$1.43

+2.88%

End of day

Market Cap

$1.86B

P/E Ratio

134.00

Employees

494

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	4.20	-1.03	-1.20	-1.20	—	-0.39
Calmar	—	24.09	-1.43	-1.26	-0.89	—	2.46
Sharpe	—	2.59	-0.77	-0.63	-0.65	—	-0.21
Omega	—	1.44	0.64	0.77	0.85	—	0.87
Martin	—	46.15	-1.96	-2.21	-1.77	—	4.91
Ulcer	0.00	3.07	48.12	38.62	37.17	—	32.72

Fangzhou Inc (6086) Price Performance

Fangzhou Inc (6086) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at HKD1.43, up 2.88% from the previous close.

Over the past year, 6086 has traded between a low of HKD1.28 and a high of HKD4.88. The stock has lost 65.7% over this period. It is currently 70.7% below its 52-week high.

Fangzhou Inc has a market capitalization of $1.86B, with a price-to-earnings ratio of 134.00.

About Fangzhou Inc

Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform; as well as operates hospitals. Fangzhou Inc. has a strategic collaboration with Youcare Pharmaceutical Group Co., Ltd. to accelerate the digital transformation and enhancement of chronic disease services through the application of artificial intelligence. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.

Company Info

Sector: Healthcare
Industry: Pharmaceutical Retailers
Exchange: Hong Kong Stock Exchange
Currency: HKD
Country: Hong Kong

Financial Metrics

Revenue (TTM): $3.53B
EBITDA: $17.04M
Profit Margin: 0.34%
EPS (TTM): -0.02
Book Value: 0.13

Technical Indicators

52 Week High: HK$5.59
52 Week Low: HK$1.20
50 Day MA: HK$1.90
200 Day MA: HK$3.09
Beta: N/A

Valuation

Trailing P/E: 134.00
Forward P/E: N/A
Price/Sales: 0.53
Price/Book: 10.37
Enterprise Value: $1.51B